Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT05512208 |
| Title | A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib (DURAFAK) |
| Acronym | DURAFAK |
| Recruitment | Recruiting |
| Gender | female |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | University of Oklahoma |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of New Mexico Comprehensive Cancer Center | RECRUITING | Albuquerque | New Mexico | 87131 | United States | Details |
| Stephenson Cancer Center | RECRUITING | Oklahoma City | Oklahoma | 73117 | United States | Details |